IACH

The International Academy for Clinical Hematology (IACH) is founded by an international group of physicians whose focus is to promote good clinical practice.

[IACH @TheIACH]

📢 Final weeks to submit your case report for Diagnostic Challenges in Lymphoma

Don't miss the opportunity to share your case with the IACH community!

🗓 Deadline: June 22

👉 For information and submission
https://t.co/782VKwEifA
#Lymphoma #Hematology #IACH2026

@Mohty_EBMT @AnnaSureda5 @MKD_BMT @MediHumdani @StefanoLuminari

[IACH @TheIACH]

📢 𝗖𝗮𝗹𝗹 𝗳𝗼𝗿 𝗖𝗮𝘀𝗲 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 - 𝗥𝗲𝘀𝗶𝗱𝗲𝗻𝘁𝘀

Facing diagnostic challenges in lymphoma?
Share your case and bring real-world complexity to the discussion at #IACH2026

✔️ Present your case
✔️ Get insights from leading experts & COLYM co-chairs
✔️ Accepted presenters receive FREE registration

🗓 Deadline: June 22

👉 For more information and submission:
https://t.co/782VKwEifA

#Lymphoma #Hematology #IACH2026

@Mohty_EBMT @AnnaSureda5 @MKD_BMT @MediHumdani @StefanoLuminari

[IACH @TheIACH]

🎧 𝗗𝗼𝗻’𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗲 𝗹𝗮𝘁𝗲𝘀𝘁 𝗳𝗿𝗼𝗺 𝗜𝗔𝗖𝗛

Catch up on all IACH podcasts from May -
expert discussions you don’t want to miss.

👉 Listen here:
https://t.co/zbA4bYK8eO

@Mohty_EBMT

[Kate Cwynarski @CwynKate]

A pleasure to discuss management of SCNSL - where we have seen significant improvement in outcome but still many challenges & areas of unmet need

More clinical & translational research required

Thank you for inviting me @TheIACH @Mohty_EBMT & for many excellent questions 👏😊

[IACH @TheIACH]

🩸𝗜𝗔𝗖𝗛 𝗮𝘁 𝗘𝗛𝗔 𝟮𝟬𝟮𝟲

@EHA_Hematology @Mohty_EBMT

[IACH @TheIACH]

📢𝗪𝗲 𝗮𝗿𝗲 𝗟𝗜𝗩𝗘

𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝗖𝗡𝗦 𝗜𝗻𝘃𝗼𝗹𝘃𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝗟𝗮𝗿𝗴𝗲 𝗕-𝗖𝗲𝗹𝗹 𝗟𝘆𝗺𝗽𝗵𝗼𝗺𝗮
𝘸𝘪𝘵𝘩 𝘒𝘢𝘵𝘦 𝘊𝘸𝘺𝘯𝘢𝘳𝘴𝘬𝘪

🎟️ 𝘍𝘙𝘌𝘌 𝘳𝘦𝘨𝘪𝘴𝘵𝘳𝘢𝘵𝘪𝘰𝘯
https://t.co/oYQh2oJPFF

@Mohty_EBMT @CwynKate

[IACH @TheIACH]

📣𝘏𝘢𝘱𝘱𝘦𝘯𝘪𝘯𝘨 𝘵𝘰𝘥𝘢𝘺

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘🔽
https://t.co/KhGn6F7OdR

@Mohty_EBMT @CwynKate

[IACH @TheIACH]

🚨𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘜𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:

𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗼𝗳 𝗦𝗲𝗰𝗼𝗻𝗱𝗮𝗿𝘆 𝗖𝗡𝗦 𝗜𝗻𝘃𝗼𝗹𝘃𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝗟𝗮𝗿𝗴𝗲 𝗕-𝗖𝗲𝗹𝗹 𝗟𝘆𝗺𝗽𝗵𝗼𝗺𝗮
𝘸𝘪𝘵𝘩 𝘒𝘢𝘵𝘦 𝘊𝘸𝘺𝘯𝘢𝘳𝘴𝘬𝘪

🗓️ 𝘞𝘦𝘥𝘯𝘦𝘴𝘥𝘢𝘺, 𝘑𝘶𝘯𝘦 3 2026
⏲️ 6 𝘗𝘔 𝘊𝘌𝘛, 12 𝘗𝘔 𝘕𝘠

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘🔽
https://t.co/AcP5nEAKgx

@Mohty_EBMT @CwynKate

[IACH @TheIACH]

🚨𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘜𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘐𝘈𝘊𝘏 𝘛𝘳𝘢𝘯𝘴𝘱𝘭𝘢𝘯𝘵 𝘈𝘤𝘢𝘥𝘦𝘮𝘺 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:

𝗛𝗟𝗔 𝗺𝗮𝘁𝗰𝗵𝗶𝗻𝗴 𝗶𝗻 𝗛𝗖𝗧: 𝗻𝗲𝘄 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝘁𝗵𝗲 𝗘𝗕𝗠𝗧
𝘸𝘪𝘵𝘩 𝘈𝘯𝘯𝘢𝘭𝘪𝘴𝘢 𝘙𝘶𝘨𝘨𝘦𝘳𝘪

🗓️ 𝘔𝘰𝘯𝘥𝘢𝘺, 𝘑𝘶𝘯𝘦 8 2026
⏲️ 6 𝘗𝘔 𝘊𝘌𝘛, 12 𝘗𝘔 𝘕𝘠

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘🔽
https://t.co/o4mtq6h93V

@AnnalisaRugger1 @Mohty_EBMT

[IACH @TheIACH]

🚨𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 - 𝘓𝘪𝘷𝘦 𝘧𝘳𝘰𝘮 #𝘈𝘚𝘊𝘖26

𝗣��𝗶𝗹𝗮𝗱𝗲𝗹𝗽𝗵𝗶𝗮-𝗣𝗼𝘀𝗶𝘁𝗶𝘃𝗲 𝗔𝗟𝗟: 𝗧𝗵𝗲 𝗘𝗻𝗱 𝗼𝗳 𝗖𝗵𝗲𝗺𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗕𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴 𝗼𝗳 𝗮 𝗡𝗲𝘄 𝗘𝗿𝗮?
🔽🔽
https://t.co/nQJ69JzlkZ

𝘊𝘭𝘪𝘤𝘬 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘢𝘣𝘴𝘵𝘳𝘢𝘤𝘵👇
https://t.co/Blk8ZipGlL

@Mohty_EBMT

[IACH @TheIACH]

📢𝗪𝗲 𝗮𝗿𝗲 𝗟𝗜𝗩𝗘

𝗖𝗼𝗮𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗗𝗶𝘀𝘁𝘂𝗿𝗯𝗮𝗻𝗰𝗲𝘀 𝗶𝗻 𝗔𝗰𝘂𝘁𝗲 𝗟𝗲𝘂𝗸𝗲𝗺𝗶𝗮: 𝗕𝗶𝗼𝗹𝗼𝗴𝘆, 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀, 𝗮𝗻𝗱 𝗕𝗲𝗱𝘀𝗶𝗱𝗲 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁
𝘸𝘪𝘵𝘩 𝘛𝘢𝘭𝘩𝘢 𝘉𝘢𝘥𝘢𝘳

🎟️ 𝘍𝘙𝘌𝘌 𝘳𝘦𝘨𝘪𝘴𝘵𝘳𝘢𝘵𝘪𝘰𝘯
https://t.co/35d0vthimU

@Mohty_EBMT @TalhaBadarMD

[IACH @TheIACH]

🚨𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 - 𝘓𝘪𝘷𝘦 𝘧𝘳𝘰𝘮 #𝘈𝘚𝘊𝘖26

𝗳��𝗼𝗻𝘁𝗠𝗜𝗡𝗗: 𝗧𝗵𝗲 𝗙𝗶𝗿𝘀𝘁 𝗥𝗲𝗮𝗹 𝗖𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲 𝘁𝗼 𝗥-𝗖𝗛𝗢𝗣 𝗶𝗻 𝗛𝗶𝗴𝗵-𝗥𝗶𝘀𝗸 𝗗𝗟𝗕𝗖𝗟?
🔽🔽
https://t.co/ACJe3SjL8y

𝘊𝘭𝘪𝘤𝘬 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘢𝘣𝘴𝘵𝘳𝘢𝘤𝘵👇
https://t.co/CWFh13VC0d

@Mohty_EBMT

[IACH @TheIACH]

👉𝘏𝘢𝘱𝘱𝘦𝘯𝘪𝘯𝘨 𝘵𝘰𝘥𝘢𝘺

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘🔽
https://t.co/KbgalYxdH5

@TalhaBadarMD @Mohty_EBMT

[IACH @TheIACH]

🚨𝘑𝘰𝘪𝘯 𝘶𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘜𝘱𝘤𝘰𝘮𝘪𝘯𝘨 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:

𝗖𝗼𝗮𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗗𝗶𝘀𝘁𝘂𝗿𝗯𝗮𝗻𝗰𝗲𝘀 𝗶𝗻 𝗔𝗰𝘂𝘁𝗲 𝗟𝗲𝘂𝗸𝗲𝗺𝗶𝗮: 𝗕𝗶𝗼𝗹𝗼𝗴𝘆, 𝗕𝗶𝗼𝗺𝗮𝗿𝗸𝗲𝗿𝘀, 𝗮𝗻𝗱 𝗕𝗲𝗱𝘀𝗶𝗱𝗲 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁
𝘸𝘪𝘵𝘩 𝘛𝘢𝘭𝘩𝘢 𝘉𝘢𝘥𝘢𝘳

🗓️ 𝘔𝘰𝘯𝘥𝘢𝘺, 𝘑𝘶𝘯𝘦 1 2026
⏲️ 6 𝘗𝘔 𝘊𝘌𝘛, 12 𝘗𝘔 𝘕𝘠

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘🔽
https://t.co/35d0vtgKxm

@Mohty_EBMT @TalhaBadarMD

[Mohamad Mohty @Mohty_EBMT]

Thought of the day at #ASCO26
SUCCESSOR-2 + MAJESTEC-9 = the age of immune dominance in myeloma !
From SUCCESSOR to MAJESTEC, immunomodulation empowers immunotherapy !
@TheIACH @COMyCongress
#Immunotherapy #CELMoD #Bispecifics

[Mohamad Mohty @Mohty_EBMT]

I know almost nothing about pancreatic cancer.
But I know enough to recognize what hope looks like.
A couple of curves can sometimes tell a bigger story: SCIENCE pushing back against the impossible. @TheIACH @COMyCongress
#ASCO26 #Hope #CancerResearch

[Mohamad Mohty @Mohty_EBMT]

#ASCO26 The Debate of the Day?
One of the most controversial topics in myeloma today. There is perhaps no definitive answer yet.
Progress comes from challenging perspectives! We may not settle the debate today, but every debate brings us closer to better care for pts. @TheIACH

[Mohamad Mohty @Mohty_EBMT]

Clin Hematol Int: Case Reports is the new peer-reviewed open access journal launched by @TheIACH
Please share your best cases.

https://t.co/ZXHCU0erJI

[IACH @TheIACH]

💡 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴: 𝘉𝘦𝘺𝘰𝘯𝘥 𝘵𝘩𝘦 𝘞𝘦𝘣𝘪𝘯𝘢𝘳

𝗖𝗮𝗻 𝗪𝗲 𝗙𝗶𝗻𝗮𝗹𝗹𝘆 𝗠𝗼𝗱𝗶𝗳𝘆 𝘁𝗵𝗲 𝗡𝗮𝘁𝘂𝗿𝗮𝗹 𝗛𝗶𝘀𝘁𝗼𝗿𝘆 𝗼𝗳 𝗠𝘆𝗲𝗹𝗼𝗳𝗶𝗯𝗿𝗼𝘀𝗶𝘀?

🎙️𝘛𝘶𝘯𝘦 𝘪𝘯 𝘵𝘰 𝘢 𝘯𝘦𝘸 𝘱𝘰𝘥𝘤𝘢𝘴𝘵:
https://t.co/pZa4y8a8OY

🧑‍💻𝘎𝘢𝘪𝘯 𝘬𝘦𝘺 𝘵𝘢𝘬𝘦𝘢𝘸𝘢𝘺𝘴 𝘧𝘳𝘰𝘮 𝘰𝘶𝘳 𝘐𝘈𝘊𝘏 𝘞𝘦𝘣𝘪𝘯𝘢𝘳:
𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀, 𝗽𝗿𝗮𝗰𝘁𝗶𝗰𝗮𝗹 𝗺𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁, 𝗮𝗻𝗱 𝗲𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗳𝗼𝗿 𝗺𝘆𝗲𝗹𝗼𝗳𝗶𝗯𝗿𝗼𝘀𝗶𝘀

𝘞𝘢𝘵𝘤𝘩 𝘵𝘩𝘦 𝘧𝘶𝘭𝘭 𝘸𝘦𝘣𝘪𝘯𝘢𝘳 𝘧𝘰𝘳 𝘍𝘙𝘌𝘌🔽
https://t.co/ABh0bUuxPM

@Mohty_EBMT

[IACH @TheIACH]

🚨𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 - 𝘓𝘪𝘷𝘦 𝘧𝘳𝘰𝘮 #𝘈𝘚𝘊𝘖26

𝗦��𝗖𝗖𝗘𝗦𝗦𝗢𝗥-𝟮: 𝗛𝗮𝘀 𝗠𝗲𝘇𝗶𝗴𝗱𝗼𝗺𝗶𝗱𝗲 𝗝𝘂𝘀𝘁 𝗥𝗲𝗱𝗲𝗳𝗶𝗻𝗲𝗱 𝗥𝗲𝗹𝗮𝗽𝘀𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗶𝗻 𝗠𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗠𝘆𝗲𝗹𝗼𝗺𝗮?
🔽🔽
https://t.co/sDPEsyjNnH

𝘊𝘭𝘪𝘤𝘬 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘱𝘳𝘦𝘴𝘴 𝘳𝘦𝘭𝘦𝘢𝘴𝘦👇
https://t.co/lHKl47YbtY

@Mohty_EBMT

[IACH @TheIACH]

🚨𝘐𝘈𝘊𝘏 𝘕𝘦𝘸𝘴 - 𝘓𝘪𝘷𝘦 𝘧𝘳𝘰𝘮 #𝘈𝘚𝘊𝘖26

𝗔��𝗖𝗢 𝟮𝟬𝟮𝟲: 𝗧𝗲𝗰𝗹𝗶𝘀𝘁𝗮𝗺𝗮𝗯 𝗖𝗵𝗮𝗻𝗴𝗲𝘀 𝘁𝗵𝗲 𝗥𝘂𝗹𝗲𝘀 𝗮𝘁 𝗙𝗶𝗿𝘀𝘁 𝗥𝗲𝗹𝗮𝗽𝘀𝗲 - 𝗧𝗵𝗲 𝗣𝗿𝗮𝗰𝘁𝗶𝗰𝗲-𝗖𝗵𝗮𝗻𝗴𝗶𝗻𝗴 𝗠𝗮𝗷𝗲𝘀𝗧𝗘𝗖-𝟵 𝗧𝗿𝗶𝗮𝗹
🔽🔽
https://t.co/62ziNKnRcs

@Mohty_EBMT